Rajaa Elmeskini

6PUBLICATIONS
65CO-AUTHORS
Molecular targetsTumour immunologyCarbon capture engineering (excl. sequestration)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 02, 2026
HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc-driven small cell lung cancer.

|Apr 22, 2026
Blockade of Tumor-Intrinsic TGFβ Signaling Drives Hyperprogression in Small Cell Lung Cancer.

|Feb 17, 2024
Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer.

Christopher W Schultz, Yang Zhang, Rajaa Elmeskini

|Jan 26, 2024
Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer.

Nitin Roper, Rajaa El Meskini, Tapan Maity

|Jul 26, 2023
ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer.

Christopher W Schultz, Yang Zhang, Rajaa Elmeskini

|Apr 20, 2022
Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models.

Delphine Lissa, Nobuyuki Takahashi, Parth Desai

Pageof 1

Frequent Collaborators

6 joint publications

Devon Atkinson

5 joint publications

Zoe Weaver Ohler

5 joint publications

Anish Thomas

3 joint publications

Yves Pommier